You can:
Name | Pyroglutamylated RF-amide peptide receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | QRFPR |
Synonym | QRFP receptor peptide p518 receptor Orexigenic neuropeptide QRFP receptor GPR103 G-protein coupled receptor 103 [ Show all ] |
Disease | N/A |
Length | 431 |
Amino acid sequence | MQALNITPEQFSRLLRDHNLTREQFIALYRLRPLVYTPELPGRAKLALVLTGVLIFALALFGNALVFYVVTRSKAMRTVTNIFICSLALSDLLITFFCIPVTMLQNISDNWLGGAFICKMVPFVQSTAVVTEILTMTCIAVERHQGLVHPFKMKWQYTNRRAFTMLGVVWLVAVIVGSPMWHVQQLEIKYDFLYEKEHICCLEEWTSPVHQKIYTTFILVILFLLPLMVMLILYSKIGYELWIKKRVGDGSVLRTIHGKEMSKIARKKKRAVIMMVTVVALFAVCWAPFHVVHMMIEYSNFEKEYDDVTIKMIFAIVQIIGFSNSICNPIVYAFMNENFKKNVLSAVCYCIVNKTFSPAQRHGNSGITMMRKKAKFSLRENPVEETKGEAFSDGNIEVKLCEQTEEKKKLKRHLALFRSELAENSPLDSGH |
UniProt | Q96P65 |
Protein Data Bank | N/A |
GPCR-HGmod model | Q96P65 |
3D structure model | This predicted structure model is from GPCR-EXP Q96P65. |
BioLiP | N/A |
Therapeutic Target Database | N/A |
ChEMBL | CHEMBL5852 |
IUPHAR | 333 |
DrugBank | N/A |
Name | BDBM50347849 |
---|---|
Molecular formula | C125H192N36O36 |
IUPAC name | (4S)-5-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[2-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-(benzylamino)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-1,4-dioxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[2-[[(2S)-2-[[(2S)-1-[2-[[(2S)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-4-oxobutanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-5-oxopentanoic acid |
Molecular weight | 2775.13 |
Hydrogen bond acceptor | 41 |
Hydrogen bond donor | 40 |
XlogP | -14.1 |
Synonyms | N/A |
Inchi Key | SGBKYVPURRZUNH-JWXYZOMLSA-N |
Inchi ID | InChI=1S/C125H192N36O36/c1-66(2)49-82(157-122(196)93-35-24-48-161(93)100(173)62-142-109(183)90(63-162)160-123(197)103(130)70(8)165)107(181)140-61-99(172)146-89(56-95(129)168)119(193)154-83(50-67(3)4)114(188)143-69(7)104(178)147-80(40-42-101(174)175)112(186)152-81(41-43-102(176)177)113(187)153-84(51-68(5)6)115(189)156-88(55-94(128)167)108(182)141-60-98(171)145-86(54-73-36-38-75(166)39-37-73)117(191)158-91(64-163)120(194)151-79(34-23-47-136-125(133)134)111(185)150-78(32-19-21-45-127)110(184)148-76(31-18-20-44-126)106(180)139-58-96(169)137-59-97(170)144-85(52-71-25-12-9-13-26-71)116(190)159-92(65-164)121(195)155-87(53-72-27-14-10-15-28-72)118(192)149-77(33-22-46-135-124(131)132)105(179)138-57-74-29-16-11-17-30-74/h9-17,25-30,36-39,66-70,76-93,103,162-166H,18-24,31-35,40-65,126-127,130H2,1-8H3,(H2,128,167)(H2,129,168)(H,137,169)(H,138,179)(H,139,180)(H,140,181)(H,141,182)(H,142,183)(H,143,188)(H,144,170)(H,145,171)(H,146,172)(H,147,178)(H,148,184)(H,149,192)(H,150,185)(H,151,194)(H,152,186)(H,153,187)(H,154,193)(H,155,195)(H,156,189)(H,157,196)(H,158,191)(H,159,190)(H,160,197)(H,174,175)(H,176,177)(H4,131,132,135)(H4,133,134,136)/t69-,70+,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,103-/m0/s1 |
PubChem CID | 91932316 |
ChEMBL | CHEMBL1802482 |
IUPHAR | N/A |
BindingDB | 50347849 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
EC50 | 67.0 nM | PMID21623631 | BindingDB,ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417